1,720,987 research outputs found
Prevalence and clinical picture of celiac disease in Turner syndrome
No full textPrevalence and clinical picture of celiac disease in Turner syndrome.
Bonamico M1, Pasquino AM, Mariani P, Danesi HM, Culasso F, Mazzanti L, Petri A, Bona G; Italian Society Of Pediatric Gastroenterology Hepatology (SIGEP); Italian Study Group for Turner Syndrom (ISGTS).
Author information 1Department of Pediatrics, University of Rome La Sapienza, 00161 Roma, Italy.
Abstract
A multicenter study of Turner syndrome (TS) patients was carried out to estimate the prevalence of celiac disease (CD) and to detect clinical characteristics and laboratory data of affected patients. Three hundred eighty-nine girls with TS were screened by IgA antigliadin antibodies and/or antiendomysial antibodies. Intestinal biopsy was offered to positive cases. CD was diagnosed in 25 patients. In celiac subjects, anemia, anorexia, and delayed growth (with respect to Italian TS curves) were frequently present; whereas distended abdomen, chronic diarrhea, constipation, and vomiting occurred more rarely. In addition, low serum iron levels, hemoglobinemia, and high values of aminotransferases were observed. Ten patients showed classic CD, 8 showed atypical symptoms, and 7 showed a silent CD. In 11 symptomatic patients, the diagnosis of CD was made at the onset of symptoms, whereas 7 of them showed a median delay of 79 months in diagnosis. Other autoimmune disorders were observed in 40% of the patients. Our study confirms the high prevalence (6.4%) of CD in a large series of TS patients. Moreover, the subclinical picture in 60% of the cases, the diagnostic delay, and the incidence of other autoimmune disorders suggest that routine screening of CD in TS is indicated
Adult height in sixty girls with Turner syndrome treated with growth hormone matched with an untreated group.
No full textUse of combined Gn-RH agonist and hGH therapy for better attaining the goals in precocious puberty
No full textFinal height attainment and gonadal function in girls with precocious puberty treated with cyproterone acetate
No full textFinal height outcome in both untreated and testosterone-treated boys with constitutional delay of growth and puberty
No full textThe present retrospective study is based on a historical follow-up of 49 boys with constitutional delay of growth and puberty (CDGP) who went into puberty spontaneously (27 cases) or induced by depotestosterone treatment, 50 mg/month for 6 months (22 cases), At the time of puberty the two groups of boys were similar in bone age, height deficiency, target height (TH) and had similar predicted final heights (FH). Their FH was measured and compared with TH calculated from measured parents' heights. FH did not significantly differ between the untreated boys and those treated, In the two groups of patients FH was similar and corresponded to both TH and height predicted at puberty onset, This study confirms that most boys with CDGP spontaneously attain a FH within the target range (24/27 cases), A short-term and low dose course of depotestosterone can be used without adverse effects on FH, The Bayley-Pinneau method can be generally considered accurate for predicting FH in CDGP, although significant discrepancies between FH and predicted height have been recorded in a fair number of both untreated and treated boys
Final height outcome in both untreated and testosterone-treated boys with constitutional delay of growth and puberty.
No full text- …
